Navigation Links
HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
Date:6/25/2008

KING OF PRUSSIA, Pa., June 25 /PRNewswire/ -- HighPoint Solutions LLC, a premier provider of business-driven IT solutions, announced today it has been selected to develop an Incentive Compensation Plan for a new Benign Prostatic Hyperplasia (BPH) product currently under FDA approval review. With the project's completion targeted for late summer 2008, the goal of the compensation plan is to motivate the field sales force and ensure the alignment of tactical activities with the product's strategic goals and budgets.

HighPoint Solutions has partnered with Qforma, the leader in advanced analytics and predictive modeling for pharmaceutical companies, on the initiative. Using a physician target universe built from Qforma's iQMap(TM), HighPoint Solutions will develop the incentive compensation plans for the launch product across all levels of the organization to drive the product's success.

"Our client is launching its new product in a crowded marketplace where the gold standard drug is going generic in 2010. It is crucial that a plan is developed offering the right balance of motivation for the sales team and realistic product uptake, while remaining within the product's budget," explained Chris Colapietro, vice president of Strategy and Marketing at HighPoint Solutions.

Alan Reicheg, Qforma's senior vice president of Commercial Operations, added, "Advances in analytics are revealing customer behaviors and emerging market shifts that point to opportunities, which can be measured and quantified in the BPH market. This type of precision targeting is now benchmark technology and our client will use it to make well-informed, strategic sales and marketing decisions."

This project combines HighPoint Solutions' industry expertise with Qforma's advanced technologies, to uncover, interpret and utilize insights from prescribing and customer peer interactions present in large data sets -- ultimately increasing sales and marketing effectiveness whil
'/>"/>

SOURCE HighPoint Solutions LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
2. Critical Homecare Solutions Holdings, Inc. Reports Full Year 2007 and First Quarter 2008 Results
3. SXC Health Solutions announces three-year $35 million PBM contract with the State of Tennessee
4. Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
5. SXC Health Solutions to Present at the Jefferies 2nd Annual Healthcare Conference
6. AHIP Selects HealthTrio to Join AHIP Solutions Program
7. SXC Health Solutions announces Mark Thierer to be named President & CEO
8. DST Health Solutions(R) and Colorado Access Extend Agreement for Business Process Outsourcing Services
9. Microsoft to Showcase Innovative Solutions for Health Plans at AHIP Institute 2008
10. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
11. Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Randy Dotinga HealthDay Reporter ... that causes malaria is growing increasingly resistant to the drugs ... But several new drugs are in development, and at least ... this global killer. "Although there has been considerable progress ... malaria is far from won, and there is still much ...
(Date:7/31/2014)... Recently, Agebc.com, a popular online shop of wedding dresses ... of trendy mother of the bride dresses . Aside ... now, up to 68% off. , “We are proud ... of mother of the bride dresses. We launch the special ... our online shop has received thousands of rave reviews from ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... Certified Internet Marketing Company, has introduced a new ... quite affordable.     , Ethane Web Technologies has designed ... the expectations of clients and Java Development service ... has given the company a confidence to promise ...
(Date:7/31/2014)... the dentist isn,t fun for anyone, but for those with ... discovery may have them smiling. In a report appearing in ... Leukocyte Biology , one of the most important blood ... shown to promote inflammation and bone loss in type 2 ... treatments that manipulate the responses of B cells may treat ...
(Date:7/31/2014)... Mirada, CA (PRWEB) July 31, 2014 ... leading healthcare providers, strives in maintaining the highest ... employers. That is why Healthpointe is offering ... to surrounding employers, employees and patients. They also ... insurance carriers. , Healthpointe’s Occupational Medicine services include, ...
Breaking Medicine News(10 mins):Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2
... VSCP ), a leading provider of quantitative ... the company,s chief executive,officer, will be presenting a corporate ... Conference at the Waldorf Astoria in New York City. ... at 3:45pm EST. , A ...
... finds all breaks, not just hip fractures, tied to increased ... fracture that occurs in people over age 60 needs to ... the Australian researchers found the risk of dying goes up ... for at least 10 years after a hip fracture. , ...
... former Senator Tom Daschle withdrew his name for consideration ... Human Services Department (HHS). From the beginning Senator ... for President Obama for a government takeover of our ... record while in the Senate, Family Research Council has ...
... Nearly three out of four Americans (71 ... cost of addiction treatment - yet most consumers ... would pay for substance abuse treatment, according to ... Hazelden, the national nonprofit organization that helps people ...
... until third year, study finds , , TUESDAY, Feb. ... period" for hormone replacement therapy has been identified ... that using estrogen-plus-progesterone therapy increases the risk for ... than taking estrogen alone. , The finding follows ...
... One-fifth of women who should receive radiation after a ... to a new study from researchers at the University ... at 396 women who were treated with a mastectomy ... of women who fell clearly within guidelines recommending radiation ...
Cached Medicine News:Health News:VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference 2Health News:Fractures in Older Adults Up Death Risk 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 3Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 4Health News:2 Years of Hormone Use May Be 'Safe' 2Health News:19 percent of breast cancer patients don’t receive recommended radiation after mastectomy 2
(Date:7/31/2014)... Quebec, July 31, 2014   , 2014 Second ... the prior year , Overall organic growth was 4% for ... injectable products; Bausch + Lomb grew 12% , 2014 ... of 43% , 2014 Second Quarter GAAP Operating Cash ... , Highlights of the Second Quarter , Launched 17 ...
(Date:7/31/2014)... 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that the Company will receive ... partner Asahi Kasei Pharma Corporation (Asahi Kasei). The ... of a regulatory application to the Japanese Pharmaceutical ... (collagenase clostridium histolyticum) for the treatment of ...
(Date:7/31/2014)... 2014 MarketResearchreports.biz presents this most ... (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and ... and Forecast (Value and Volume), 2013 - 2019: Market ... growing at an exponential rate worldwide, has become a ... major cause of death of people between 20 years ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... First Pro-Healing Stent Also ... Featured at Annual Symposium, ... the subject of several sessions about,innovation in interventional cardiology strategies ... 2007,which is set for Oct. 20-25 at the Washington Convention ...
... Bono Initiative Aims to Mobilize $25 Million to Eliminate ... Afflicting the Poorest of the Poor, EAST RUTHERFORD, N.J., ... nation,s top ten public relations firms, was,highlighted by President Bill ... for its key role in the fight against diseases of,poverty ...
Cached Medicine Technology:OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 3President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 4
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 600....
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 700....
Designed to remove cell debris or tissue remnants from the retina....
... Medtronic presents the Streamline family of ... have taken the gold standard in temporary ... that make them easy to use and ... Streamline Temporary Pacing Leads are designed to ...
Medicine Products: